LHDXQ — Lucira Health Share News
0.000.00%
FinancialsHighly SpeculativeMicro Cap
- $0.00m
- -$10.36m
- $93.06m
Refile: BUZZ-U.S. STOCKS ON THE MOVE-Gold miners, Starbucks, ASLAN Pharma
U.S. STOCKS ON THE MOVE-Jasper Therapeutics, Blackstone, Mondelez
U.S. STOCKS ON THE MOVE-Horizon Global, Apple, PayPal Holdings
Lucira up on filing for authorization of over-the-counter use of COVID, flu test
Brief: Lucira Health Submits EUA For Over-The-Counter Use Of Its Covid-19 & Flu Test
Brief: Lucira Health Voluntarily Terminated Its Loan And Security Agreement
Brief: Lucira Health Inc - On December 13, Co Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: Lucira And Loch Lomond Villa Announce Clinical Study To Tackle Tripledemic With First And Only Combination Covid-19 And Flu OTC Molecular Self-Test
Brief: Lucira Health Announces FDA Authorization Of Combination Covid-19 & Flu Test At Point-Of-Care
U.S. STOCKS ON THE MOVE-CytomX, Immunic, Macy's
Lucira rises on digital health service launch
Brief: Lucira Health Announces National Launch Of Lucira Connect Test-To-Treat Service
Lucira Health Inc reports results for the quarter ended in September - Earnings Summary
Brief: Lucira Health Announces Third Quarter 2022 Results
Lucira Health Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: Lucira Health Inc - On Oct 20, Board Approved Reduction In Force Involving 56 Employees, Representing Approximately 25.0% Of The Company’S Workforce
Brief: Lucira Health Posts Pilot Study Interim Results For Chlamydia And Gonorrhea Assays
Lucira Health falls on weak Q2 COVID test sales
Brief: Lucira Health Announces Q2 Results And Provides Business Updates